Britain’s National Health Service will no longer routinely prescribe puberty blockers to children amid concerns over a lack of evidence on the impact of the so-called gender-affirming drugs. In what is being described as a historical moment, the UK’s state healthcare provider will no longer be prescribing children with life-altering puberty blockers except in exceptional